Neurologic complications following hematopoietic stem cell transplantation. Study of 14 patients;Complicaciones neurológicas después de un trasplante de progenitores hemopoyéticos. Estudio de 14 pacientes

Medicina Clinica

Volumn 125, Issue 18, 2005, Pages 697-699

  Batlle, Montserrat ^a,b   Oriol, Albert ^a   Ribera, Josep Maria ^a   Lozano, Manuel ^a   Ferrà, Christelle ^a   Sancho, Juan Manuel ^a   Xicoy, Blanca ^a   Feliu, Evarist ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Hematopoietic stem cell transplantation; Neurologic complications; Toxicity drug

Indexed keywords

ACICLOVIR; BUSULFAN; CEFEPIME; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; FLUCONAZOLE; FLUDARABINE; FOSCARNET; IMIPENEM; MELPHALAN; METHOTREXATE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BRAIN DISEASE; BRAIN HEMORRHAGE; CAUSE OF DEATH; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYCOSIS; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SEIZURE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; VIRUS ENCEPHALITIS;

EID: 29844439674     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(05)72159-x     Document Type: Article

References (12)

1. Krouwer H, Wijdicks E. Neurologic complications of bone marrow transplantation. Neurol Clin N Am. 2003;21:319-52.
2. De Brabender C, Cornelissen J, Sillevis Smitt PAE, Vecht C, Van den Bent J. Increased incidence of neurological complication in patients receiving an allogenic bone marrow transplantation from alternative donors. Neurol Neurosurg Psychiatry. 2000;68:36-40.
3. Kishi Y, Miyakoshi S, Kami M, Katayama Y, Mirashige N, Kusumi E, et al. Early central nervous system complications after reduced-intensity stem cell transplantation. Biol Blood Marrow Transplant. 2004;10:561-8.
4. Snider S, Bashir R, Bierman P. Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurology. 1994;44:681-4.
5. Bleggi-Torres LF, De Medeiros BC, Werner B, Zanis Neto J, Loddo G, Pasquini R, et al. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant. 2000;25:301-7.
6. Gallardo D, Ferra C, Berlanga JJ, De la Banda E, Ponce C, Salar A, et al. Neurologic complications arter allogenic bone marrow transplantation. Bone Marrow Transplant. 1996;18:1135-9.
7. Graus F, Saiz A, Sierra J, Arbaiza D, Rovira M, Carreras E, et al. Neurologic complications of autologous and allogenic bone marrow transplantation in patients with leukemia: a comparative study. Neurology. 1996;46:1004-9.
8. Antonini G, Ceschin V, Morino S, Fiorelli M, Gragnani F, Mengarelli A, et al. Early neurologic complicactions following allogeneic bone marrow transplant for leukemia. A prospective study. Neurology. 1998;50:1441-5.
9. Turhal NS. Cyclosporin A and imipenem associated seizure activity in allogeneic bone marrow transplantation patients. J Chemother. 1999;11:410-3.
10. Plensa E, Gallardo E, Ribera JM, Batlle M, Oriol A, Costa J. Nonconvulsive status epilepticus associated with cefepime in a patient undergoing autologous stem cell transplantation. Bone Marrow Transplant. 2004;33:119-20.
11. Ruutu T, Hermans J, Nierderwiesser D, Gratwohl A, Kiehl M, Volin L, et al. Thrombotic thrombocytopenic purpura after allogenic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol. 2002;118:1112-9.
12. Mohrmann RL, Mah V, Vinters HV. Neurologic findings after bone marrow transplantation. Hum Pathol. 1990;21:630-9.